Search research articles
Contact Us
Filters
Showing results (11-20 of 83) with videos related to
Page
of 9
Sort By:
European Journal of Haematology
|
September 9, 2005
Intravascular lymphoma associated with haemophagocytic syndrome: a very rare entity in western countries
Benjamin Terrier, Achille Aouba, Viorel Vasiliu, et al.
Expert Review of Hematology
|
June 21, 2015
Prognosis and outcome of stem cell transplantation for mantle cell lymphoma
Morgane Cheminant, Stephen Robinson, Vincent Ribrag, et al.
Journal of Clinical Microbiology
|
May 8, 2003
Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma
Marianne Leruez-Ville, Marie Ouachée, Richard Delarue, et al.
Clinical Lymphoma & Myeloma
|
July 11, 2007
Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome
Nadège Wallet, David Ghez, Richard Delarue, et al.
BMJ Case Reports
|
August 11, 2011
Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?
Marie-Olivia Chandesris, David Ghez, Caroline Besson, et al.
Ophthalmology
|
December 7, 2007
Endogenous erythroid colony formation in patients with retinal vein occlusion
Emmanuel Héron, Christophe Marzac, Sylvie Feldman-Billard, et al.
Leukemia & Lymphoma
|
June 7, 2012
Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma
Bénédicte Deau, Emmanuel Bachy, Vincent Ribrag, et al.
Transplantation
|
November 10, 2009
Rapamycin for refractory acute graft-versus-host disease
David Ghez, Marie Thérèse Rubio, Natacha Maillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2008
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study
Catherine Sebban, Pauline Brice, Richard Delarue, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2013
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial
Franck Morschhauser, Olivier Fitoussi, Corinne Haioun, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 83) with videos related to
Sort By:
Page
of 9
European Journal of Haematology
|
September 9, 2005
Intravascular lymphoma associated with haemophagocytic syndrome: a very rare entity in western countries
Benjamin Terrier, Achille Aouba, Viorel Vasiliu, et al.
Expert Review of Hematology
|
June 21, 2015
Prognosis and outcome of stem cell transplantation for mantle cell lymphoma
Morgane Cheminant, Stephen Robinson, Vincent Ribrag, et al.
Journal of Clinical Microbiology
|
May 8, 2003
Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma
Marianne Leruez-Ville, Marie Ouachée, Richard Delarue, et al.
Clinical Lymphoma & Myeloma
|
July 11, 2007
Diffuse large B-cell lymphoma in hyperimmunoglobulinemia E syndrome
Nadège Wallet, David Ghez, Richard Delarue, et al.
BMJ Case Reports
|
August 11, 2011
Complete remission of a relapsing adult T cell leukaemia following treatment of a secondary acute promyelocytic leukaemia: towards a reappraisal of arsenic trioxide and all-transretinoic acid?
Marie-Olivia Chandesris, David Ghez, Caroline Besson, et al.
Ophthalmology
|
December 7, 2007
Endogenous erythroid colony formation in patients with retinal vein occlusion
Emmanuel Héron, Christophe Marzac, Sylvie Feldman-Billard, et al.
Leukemia & Lymphoma
|
June 7, 2012
Macrophage, mast cell and T lymphocyte infiltrations are independent predictive biomarkers of primary refractoriness or early relapse in classical Hodgkin lymphoma
Bénédicte Deau, Emmanuel Bachy, Vincent Ribrag, et al.
Transplantation
|
November 10, 2009
Rapamycin for refractory acute graft-versus-host disease
David Ghez, Marie Thérèse Rubio, Natacha Maillard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 19, 2008
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA study
Catherine Sebban, Pauline Brice, Richard Delarue, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 5, 2013
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trial
Franck Morschhauser, Olivier Fitoussi, Corinne Haioun, et al.
Page
of 9